Clinical Trial with vancomycin for PSC

FYI I recently learned that all three Mayo Clinic sites are recruiting again for the FDA trial on vancomycin as a treatment for PSC. There is now an option to have the study drug mailed to study participants and there is a study monitor who watches results and will move to terminate the trial if effectiveness of the drug is high. I can answer most questions about the trial or patients with interest in the Vancomycin study can reach out to the following coordinators (I co-wrote the original grant application). You can mention me to the coordinator at the site you select:

Rochester:

Mitchell Clayton

Clayton.mitchell@mayo.edu

507-284-2698

Arizona:

Megan Kelly (covering for Saran Vaughn who is on leave)

Kelly.megan1@mayo.edu

480-342-1248

Florida:

Robert Brannock

Brannock.robert@mayo.edu

904-953-4133

Great. I believe the study is this one:

It is getting some funding from the FDA.

Yes, actually all the funding is from the FDA.